Incremental prognostic value of restrictive filling pattern in hypertrophic cardiomyopathy: a Doppler

Bruno Pinamonti1, Andrea Di Lenarda, Gaetano Nucifora

  • 1Cardiovascular Department, Azienda Ospedaliero-Universitaria Ospedali Riuniti di Trieste, Trieste, Italy. bpinamonti@hotmail.com

Insights

Restrictive filling pattern (RFP) is uncommon in hypertrophic cardiomyopathy (HCM) but indicates a higher risk of adverse cardiac events. Echocardiography-Doppler assessment of filling patterns improves prognostic accuracy in HCM patients.

Area of Science:

  • Cardiology
  • Echocardiography
  • Cardiovascular Imaging

Background:

  • Hypertrophic cardiomyopathy (HCM) is a primary cardiac disease.
  • Assessing prognostic indicators in HCM is crucial for patient management.
  • The prognostic value of restrictive filling pattern (RFP) in HCM requires further investigation.

Purpose of the Study:

  • To determine the frequency of restrictive filling pattern (RFP) in hypertrophic cardiomyopathy (HCM) patients.
  • To evaluate the incremental prognostic value of RFP in predicting adverse outcomes in HCM.

Main Methods:

  • Eighty-seven HCM patients underwent physical and Doppler echocardiographic evaluation.
  • Patients were followed for a mean of 96 months.
  • Multivariate proportional hazard models and ROC curve analysis were used to identify predictors of cardiac death or heart transplantation.

Main Results:

  • Restrictive filling pattern (RFP) was identified in 16% of HCM patients.
  • Patients with RFP exhibited higher NYHA class, more heart failure signs, and lower ejection fraction.
  • RFP was a significant independent predictor of cardiac death or heart transplantation (HR=2.94, P=0.01).
  • Inclusion of RFP and indexed left atrial diameter improved the predictive model's AUC from 0.76 to 0.84 (P=0.01).

Conclusions:

  • Restrictive filling pattern (RFP), though not frequent, is present in a notable proportion of HCM patients.
  • Echocardiography-Doppler assessment of filling patterns provides significant additional prognostic information beyond clinical stratification in HCM.
Abstract

Related Concept Videos

Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...